Personalized HIV dosing: a step toward fewer side effects
NCT ID NCT03385473
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 29 times
Summary
This study looked at whether using genetic tests and checking drug levels in the blood can help doctors choose the right dose of HIV medication for each person. 190 adults starting HIV treatment for the first time took part. The goal was to see if this personalized approach reduces side effects and keeps the treatment working well, compared to standard dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Italiano de Buenos Aires - Infectious Diseases Section
Buenos Aires, Buenos Aires F.D., 1181, Argentina
Conditions
Explore the condition pages connected to this study.